Epcoritamab for DLBCL: Bispecific Antibody Therapy, Older Patients, Response and Safety

This cancer care discussion examines Epcoritamab in Older DLBCL Patients with a focused overview of diffuse large B-cell lymphoma, R-CHOP chemotherapy, and DLBCL relapse. The video outlines CAR T-cell therapy, bispecific antibodies, and lymphoma treatment, with practical context for diagnosis, treatment sequencing, expected outcomes, and follow-up. The video is especially relevant to people searching for diffuse large B-cell lymphoma, CAR T-cell therapy, or bispecific antibodies and wanting a clearer explanation of how oncologists make treatment decisions. Relevant for anyone seeking clear, evidence-based context before discussing options with a multidisciplinary cancer team. Follow-up may include clinical review blood tests imaging or